RecruitingPhase 4NCT07221877
A Study to Evaluate the Effect of KarXT on Urological Safety
Sponsor: Bristol-Myers Squibb
Las Vegas, NV · +15 more sites
Schizophrenia clinical trials in Las Vegas, NV
8 recruiting schizophrenia studies with a site in Las Vegas, NV.
RecruitingPhase 3NCT07424404
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Las Vegas, NV · +55 more sites
RecruitingPhase 2NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Las Vegas, NV · +44 more sites
RecruitingPhase 2NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Sponsor: MapLight Therapeutics
Las Vegas, NV · +36 more sites
RecruitingPhase 3NCT06229210
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Sponsor: Intra-Cellular Therapies, Inc.
Las Vegas, NV · +58 more sites
RecruitingPhase 3NCT07369154
52-week Open Label Safety-Tolerability Study
Sponsor: LB Pharmaceuticals Inc.
Las Vegas, NV · +22 more sites
RecruitingPhase not listedNCT07379827
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Sponsor: Bristol-Myers Squibb
Las Vegas, NV · +54 more sites
RecruitingPhase 3NCT06961968
Randomized Withdrawal Study in Patients With Schizophrenia
Sponsor: Vanda Pharmaceuticals
Las Vegas, NV · +21 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.